Advertisement
GE Healthcare
GE Healthcare

Antibody-Dependent Enhanced (ADE) Immunity

The method to the dengue virus's maddening infectiousness.

By | March 2, 2013

ANTIBODY-DEPENDENT ENHANCED (ADE) IMMUNITY
ANTIBODY-DEPENDENT ENHANCED (ADE) IMMUNITY
ANTIBODY-DEPENDENT ENHANCED (ADE) IMMUNITY

View full size JPG | PDFTAMI TOLPA

ANTIBODY-DEPENDENT ENHANCED (ADE) IMMUNITY

Dengue infects by attaching to a cell that then engulfs the virus in a vacuole via endocytosis. The virus rearranges its coat proteins to bind to the vacuole membrane, releasing its capsid and genome into the cytoplasm, where it is replicated and packaged into newly made virions (1). The infected cell also triggers an immune reaction (2) that includes the recruitment of T cells that release pro-inflammatory cytokines and B cells that generate antibodies. These antibodies are specific for the infecting virus, and bind and cover dengue’s coat (3). When this happens, macrophages and monocytes clear the virus from the bloodstream by binding to and engulfing the antibody-coated viruses—which can no longer escape the endocytic vacuole—and destroying them (4).

When a person is infected with a different dengue virus type (5), memory B cells created during the first infection spring into action (6), flooding the bloodstream with antibodies specific to the first type. These antibodies, however, may not bind to the new type as well (7). As a result, when the partially-coated virions are taken up by macrophages and monocytes, they can escape the endocytic vacuole, infecting and replicating within these immune cells (8).

Read the full story.

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo
Advertisement

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Antibiotics and the Gut Microbiome
  3. Sex Differences in Pain Pathway
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
The Scientist